dr. tam on the toxicity of ibrutinib plus venetoclax in mcl
Published 6 years ago • 243 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:08
dr. tam on the toxicities of ibrutinib plus venetoclax in mcl
-
1:56
dr. tam on the combination of ibrutinib plus venetoclax in mantle cell lymphoma
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
1:02
dr. tam on zanubrutinib vs ibrutinib research in mantle cell lymphoma
-
1:27
dr. rule on the combination of venetoclax and ibrutinib in mcl
-
0:58
dr. leslie on the benefits with zanubrutinib in mcl
-
0:44
dr. tam on zanubrutinib approval in mcl
-
1:28
dr. ritchie on immunological recovery with venetoclax and ibrutinib in mcl
-
1:28
dr. karmali on the toxicity profile of ibrutinib maintenance in mcl
-
3:18
sympatico: safety and efficacy of ibrutinib plus venetoclax for r/r mcl
-
1:09
dr. ritchie on the immunologic impact of long-term venetoclax/ibrutinib in r/r mcl
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
1:01
dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
1:22
dr. kaplan on the combination of ibrutinib and venetoclax in mcl
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:22
dr. leslie on sequencing zanubrutinib in mcl
-
0:15
copy of dr. kaplan on the combination of ibrutinib and venetoclax in mcl
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl